Why are the majority of dogs with Cushing’s disease poorly managed? Insights from team RVC
17 Nov 2023
RVC Clinical Theatre 2
Cushing's syndrome is the third most commonly diagnosed endocrinopathy in dogs, with a prevelance of around 0.2% and is associated with a poorer qualty of life (QoL). Trilostane is the most commonly prescribd treated for Cushing's syndrome in the UK, and this treatment improves but does not normalise QoL. This lecture will present possible explanations why this treatment does not return QoL to normal from the viewpoint of each of the three different presenters.
SpeakersDavid Church, Deputy Principal and Acting Vice Principal Clinical Affairs, Professor of Small Animal Studies - Royal Veterinary College